Standard Biotools (LAB) EPS (Weighted Average and Diluted) (2019 - 2025)
Historic EPS (Weighted Average and Diluted) for Standard Biotools (LAB) over the last 7 years, with Q3 2025 value amounting to -$0.09.
- Standard Biotools' EPS (Weighted Average and Diluted) fell 2857.14% to -$0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.33, marking a year-over-year increase of 5352.11%. This contributed to the annual value of -$0.52 for FY2024, which is 4449.92% up from last year.
- As of Q3 2025, Standard Biotools' EPS (Weighted Average and Diluted) stood at -$0.09, which was down 2857.14% from -$0.09 recorded in Q2 2025.
- Standard Biotools' EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.07 during Q3 2024, with a 5-year trough of -$0.99 in Q1 2022.
- For the 5-year period, Standard Biotools' EPS (Weighted Average and Diluted) averaged around -$0.26, with its median value being -$0.22 (2023).
- In the last 5 years, Standard Biotools' EPS (Weighted Average and Diluted) crashed by 29600.0% in 2022 and then soared by 7878.79% in 2023.
- Over the past 5 years, Standard Biotools' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.12 in 2021, then plummeted by 108.98% to -$0.26 in 2022, then grew by 3.34% to -$0.25 in 2023, then soared by 61.62% to -$0.1 in 2024, then rose by 6.69% to -$0.09 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.09 in Q3 2025, compared to -$0.09 in Q2 2025 and -$0.07 in Q1 2025.